Trials / Sponsors / International Cancer Research Group, United Arab Emirates
International Cancer Research Group, United Arab Emirates
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Me Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer | Phase 2 | 2022-12-20 |
| Completed | Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant Breast Neoplasm Female | Phase 3 | 2017-12-20 |